Cargando…

Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens

OBJECTIVE(S): A new vaccine candidate TB/FLU-05E has been developed at the Smorodintsev Research Institute of Influenza (Russia). The vaccine is based on the attenuated influenza strain A/PR8/NS124-TB10.4-2A-HspX that expresses mycobacterial antigens TB10.4 and HspX. This article describes the resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stosman, Kira I., Aleksandrov, Andrey G., Sivak, Konstantin V., Buzitskaya, Zhanna V., Stukova, Marina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083829/ https://www.ncbi.nlm.nih.gov/pubmed/37051099 http://dx.doi.org/10.22038/IJBMS.2023.68440.14936

Ejemplares similares

Enhancement of the Local CD8(+) T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
por: Vasilyev, Kirill, et al.
Publicado: (2021)

Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs
por: Sergeeva, Mariia, et al.
Publicado: (2021)

Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis
por: Castro-Garza, Jorge, et al.
Publicado: (2017)

HspX-mediated survival pathways of pathogenic mycobacteria
por: Alhusain, Fahad
Publicado: (2021)

HspX promotes the polar localization of mycobacterial protein aggregates
por: Zhang, Yi-Wei, et al.
Publicado: (2019)

Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
por: Shurygina, Anna-Polina, et al.
Publicado: (2023)

Comparison of hspX gene sequence in the Beijing and non-Beijing Mycobacterium tuberculosis
por: Seyed Majidi, Ashkan, et al.
Publicado: (2020)

Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis
por: Rabahi, Marcelo Fouad, et al.
Publicado: (2007)

Diagnostic potential of 16 kDa (HspX, α-crystalline) antigen for serodiagnosis of tuberculosis
por: Kaushik, Amit, et al.
Publicado: (2012)

HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule
por: Taylor, Jennifer L, et al.
Publicado: (2012)

Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
por: de Sousa, Eduardo Martins, et al.
Publicado: (2012)

Development and Evaluation of a Fusion Polyprotein Based on HspX and Other Antigen Sequences for the Serodiagnosis of Tuberculosis
por: Zhou, Fangbin, et al.
Publicado: (2021)

Correction: Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection
por: de Sousa, Eduardo Martins, et al.
Publicado: (2013)

The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients
por: Silva, Bruna Daniella Souza, et al.
Publicado: (2013)

IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage
por: Jee, Babban, et al.
Publicado: (2017)

Rv2031c of Mycobacterium tuberculosis: a master regulator of Rv2028–Rv2031 (HspX) operon
por: Mushtaq, Khurram, et al.
Publicado: (2015)

Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA Impacts the Rapid Diagnosis of Tuberculous Meningitis in Children
por: Haldar, Sagarika, et al.
Publicado: (2012)

Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4′-O-(2-Fluoroethyl) Moiety and the Potential of Their (18)F-Labeled Derivatives for Neuroinflammation Imaging
por: Vaulina, Daria D., et al.
Publicado: (2021)

Hsp40s Specify Functions of Hsp104 and Hsp90 Protein Chaperone Machines
por: Reidy, Michael, et al.
Publicado: (2014)

Substrate Discrimination by ClpB and Hsp104
por: Johnston, Danielle M., et al.
Publicado: (2017)

ESAT-6 and HspX Improve the Effectiveness of BCG to Induce Human Dendritic Cells-Dependent Th1 and NK Cells Activation
por: Marongiu, Laura, et al.
Publicado: (2013)

Acute Toxicity, Immunotoxicity and Allergenicity of Protease Complex Obtained from Micromycete Sarocladium strictum
por: Alipkina, Svetlana, et al.
Publicado: (2021)

Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis
por: da Costa, Adeliane C., et al.
Publicado: (2017)

Motor Mechanism for Protein Threading through Hsp104
por: Wendler, Petra, et al.
Publicado: (2009)

Suramin Inhibits Hsp104 ATPase and Disaggregase Activity
por: Torrente, Mariana P., et al.
Publicado: (2014)

Structural basis for the disaggregase activity and regulation of Hsp104
por: Heuck, Alexander, et al.
Publicado: (2016)

Variant‐specific and reciprocal Hsp40 functions in Hsp104‐mediated prion elimination
por: Astor, Michael T., et al.
Publicado: (2018)

Coordinated Hsp110 and Hsp104 Activities Power Protein Disaggregation in Saccharomyces cerevisiae
por: Kaimal, Jayasankar Mohanakrishnan, et al.
Publicado: (2017)

A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses
por: Moradi, Bagher, et al.
Publicado: (2020)

Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food
por: Naidenko, Olga V., et al.
Publicado: (2021)

Functional analysis of proposed substrate-binding residues of Hsp104
por: Howard, Matthew K., et al.
Publicado: (2020)

Therapeutic genetic variation revealed in diverse Hsp104 homologs
por: March, Zachary M, et al.
Publicado: (2020)

Prion aggregate structure in yeast cells is determined by the Hsp104-Hsp110 disaggregase machinery
por: O’Driscoll, Jonathan, et al.
Publicado: (2015)

Formulation and Optimization of a New Cationic Lipid-Modified PLGA Nanoparticle as Delivery System for Mycobacterium tuberculosis HspX/EsxS Fusion Protein: An Experimental Design
por: Khademi, Farzad, et al.
Publicado: (2019)

In vivo assessment of immunotoxicity
por: Munson, Albert E., et al.
Publicado: (1982)

Clinical and Laboratory Studies of the Fate of Intranasal Allergen
por: Rimmer, Janet, et al.
Publicado: (2015)

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016)

Adenosine diphosphate restricts the protein remodeling activity of the Hsp104 chaperone to Hsp70 assisted disaggregation
por: Kłosowska, Agnieszka, et al.
Publicado: (2016)

Differences in the Curing of [PSI(+)] Prion by Various Methods of Hsp104 Inactivation
por: Park, Yang-Nim, et al.
Publicado: (2012)

The Schizosaccharomyces pombe Hsp104 Disaggregase Is Unable to Propagate the [PSI (+)] Prion
por: Sénéchal, Patrick, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ci47o64jcq7ejci3dm9i25ehsf